4
Changes in Ownership
Altimmune, Inc. Filed Acc 0001104659-22-075361
Chief Scientific Officer sold 37,352 shares at $12.00 ($448,254)
- Chief Scientific Officer acquired 37,352 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Roberts M Scot · Chief Scientific Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-06-27 | Exercise or conversion : show line 1 in the form | +25,583 | $1.92 | $49,153 | 43,283 | D |
| 2022-06-27 | Exercise or conversion : show line 2 in the form | +11,769 | $2.60 | $30,599 | 55,052 | D |
| 2022-06-27 | Sale : show line 3 in the form | −37,352 | $12.00 | $448,254 | 17,700 | D |
| Open-market sales · 37,352 sh · avg $12.00 · $448,254 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-06-27 | Exercise or conversion : show line 4 in the form Stock Options (option to buy) | −25,583 | 35,817 | D |
| 2022-06-27 | Exercise or conversion : show line 5 in the form Stock Options (option to buy) | −11,769 | 18,231 | D |
Loading xslF345X03/tm2219797-2_4seq1.xml…